Company intelligence / Profile preview

Moss Genomics Inc.

Vancouver, British Columbia, Canadamossgenomics.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Recently launched the Perennial platform publicly after beta testing since March 2025. The platform provides consumers with advanced genetic insights from their own biomarkers using uploaded blood test data. The company integrates blockchain technology (Ethereum) to secure genomic data privacy and user control[2][6].

They have also raised capital through private placements involving Ethereum cryptocurrency, reflecting an innovative treasury management strategy[6].

Therapeutic areas: Other
Modalities: Genomic data analysis and insights platform (digital/biotech)Microbiome research-based solutionsPersonalized health, anti-aging, and wellness products (likely nutraceutical or digital health modalities)
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Moss Genomics Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Moss Genomics Inc..

Explore the full profile